Skip to main content
Addgene

ER-moxMaple3
(Plasmid #120885)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 120885 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    ER-mRFP
  • Backbone manufacturer
    Addgene plasmid 62236
  • Modifications to backbone
    ER-RFP contains fusions of the bovine prolactin signal sequence, mRFP, and a KDEL ER retention sequence. mRFP was replaced with moxMaple3
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Kanamycin, 50 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    moxMaple3
  • Species
    Synthetic
  • Promoter CMV
  • Tags / Fusion Proteins
    • bovine prolactin signal sequence (N terminal on backbone) (N terminal on backbone)
    • KDEL ER retention sequence (C terminal on backbone)

Cloning Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Please Note: Plasmid contains a 72 basepair deletion in the SV40 promoter sequence upstream of NeoR/KanR compared to the ER-mRFP vector backbone. This deletion is not known to affect plasmid function.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    ER-moxMaple3 was a gift from Erik Snapp (Addgene plasmid # 120885 ; http://n2t.net/addgene:120885 ; RRID:Addgene_120885)
  • For your References section:

    moxMaple3: a Photoswitchable Fluorescent Protein for PALM and Protein Highlighting in Oxidizing Cellular Environments. Kaberniuk AA, Mohr MA, Verkhusha VV, Snapp EL. Sci Rep. 2018 Oct 3;8(1):14738. doi: 10.1038/s41598-018-32955-5. 10.1038/s41598-018-32955-5 PubMed 30283009